논문 목록
13건 · 최신순-
Effects of glabellar botulinum toxin injections on resting-state functional connectivity in borderline personality disorder.
Meta-analyses suggest a sustained alleviation of depressive symptoms through glabellar botulinum toxin (BTX) injections. This can be explained by the disruption of facial feedback loops, which may moderate and reinforce the experience of ne…
-
Botulinum Toxin Therapy for Psychiatric Disorders in Clinical Practice: A Retrospective Case Study.
Inhibiting the facial expression of negative emotions via botulinum toxin A (BTX) has been shown to mitigate symptoms of clinical depression in randomized controlled trials. This retrospective case study sought to reproduce the beneficial e…
-
Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial.
[BACKGROUND] Inhibition of frowning via injections of botulinum toxin A (BTX) into the glabellar region has shown beneficial effects in the treatment of major depression. Preliminary research suggests that improvements in the affective doma…
-
Treatment of Depression with Botulinum Toxin.
Injection of botulinum toxin (BoNT) into the glabellar region of the face is a novel therapeutic approach in the treatment of depression. This treatment method has several advantages, including few side effects and a long-lasting, depot-lik…
-
Neuronal effects of glabellar botulinum toxin injections using a valenced inhibition task in borderline personality disorder.
Previous studies have indicated that glabellar botulinum toxin (BTX) injections may lead to a sustained alleviation of depression. This may be accomplished by the disruption of a facial feedback loop, which potentially mitigates the experie…
-
The Use of Botulinum Toxin for Treatment of Depression.
A series of clinical studies have shown that botulinum toxin can treat major depression. Subjects suffering from unipolar depression may experience a quick, strong, and sustained improvement in the symptoms of depression after a single glab…
- Correction to: The Use of Botulinum Toxin for Treatment of Depression.
-
Botulinum toxin for the management of depression: An updated review of the evidence and meta-analysis.
Botulinum toxin (BTX) treatment of glabellar frown lines is one of the most common procedures in aesthetic medicine. In addition to its cosmetic effect, the neurotoxin has been shown to have a positive influence on mood and affect. Several …
- Reply to: "Letter to the Editor: Claims about the effects of botulinum toxin on depression should raise some eyebrows".
- Comment on effects of botulinum toxin type A on mood and cognitive function in patients with Parkinson's disease and depression.
-
Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety.
Randomized controlled trials (RCTs) have shown an antidepressant effect of glabellar botulinum toxin (BoNT) injections. In the FDA Adverse Event Reporting System (FAERS) database, BoNT injection is associated with reduced incidence rates of…
-
Botulinum toxin type D blocks autonomic cholinergic synapses in humans: discussion of a potential therapeutic use.
Based on epidemiological data it was believed that botulinumtoxin type D (BT-D) may not block human cholinergic synapses. We wanted to investigate BT-D's effect on the autonomic cholinergic synapse in humans. For this, we compared in four v…
-
Botulinum Toxin as a Treatment for Depression in a Real-world Setting.
[OBJECTIVES] A series of randomized controlled trials have shown the efficacy of glabellar botulinum toxin (BTX) injection as a treatment for depression in women. We wanted to extend these findings and assess how they may be translated to a…